We are live on ! Find out more
RHBC

R.H. Bluestein & Co Portfolio holdings

AUM $1.61B
1-Year Est. Return 7.59%
This Fund
S&P 500
This Quarter Est. Return
+9.79%
1 Year Est. Return
-7.59%
3 Year Est. Return
+69.02%
5 Year Est. Return
+139.59%
10 Year Est. Return
AUM
$2.58B
AUM Growth
+$215M
Cap. Flow
-$3.98M
Cap. Flow %
-0.15%
Top 10 Hldgs %
39.57%
Holding
443
New
37
Increased
128
Reduced
97
Closed
16

Top Buys

Rank Stock Value
1
EL icon
Estee Lauder
EL
+$31.4M
2
NFLX icon
Netflix
NFLX
+$23.5M
3
SLB icon
SLB Ltd
SLB
+$21.9M
4
KO icon
Coca-Cola
KO
+$21.8M
5
SPOT icon
Spotify
SPOT
+$21M

Top Sells

Rank Stock Value
1
FCX icon
Freeport-McMoran
FCX
+$50.2M
2
APTV icon
Aptiv
APTV
+$46.3M
3
PYPL icon
PayPal
PYPL
+$42.5M
4
CCI icon
Crown Castle
CCI
+$35.6M
5
BALL icon
Ball Corp
BALL
+$29.3M

Sector Composition

Rank Sector Weight
1 Technology 18.91%
2 Industrials 15.84%
3 Communication Services 11.91%
4 Healthcare 11.29%
5 Financials 10.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SHC icon
351
Sotera Health
SHC
$5.11B
$267K 0.01%
11,000
MGV icon
352
Vanguard Morningstar Mega Cap Value ETF
MGV
$13.5B
$266K 0.01%
2,670
NOK icon
353
Nokia
NOK
$54.2B
$266K 0.01%
50,000
KOF icon
354
Coca-Cola Femsa
KOF
$22.8B
$265K 0.01%
5,000
AMD icon
355
Advanced Micro Devices
AMD
$794B
$262K 0.01%
2,792
SHYF
356
DELISTED
The Shyft Group
SHYF
$262K 0.01%
7,000
BEAM icon
357
Beam Therapeutics
BEAM
$2.77B
$257K 0.01%
+2,000
New +$159K
VOD icon
358
Vodafone
VOD
$35.4B
$257K 0.01%
15,000
VIOV icon
359
Vanguard S&P Small-Cap 600 Value ETF
VIOV
$1.89B
$256K 0.01%
2,810
WDFC icon
360
WD-40
WDFC
$3.16B
$256K 0.01%
1,000
-1,500
-60% -$383K
AMPH icon
361
Amphastar Pharmaceuticals
AMPH
$887M
$252K 0.01%
12,500
OLLI icon
362
Ollie's Bargain Outlet
OLLI
$4.72B
$252K 0.01%
3,000
-1,500
-33% -$131K
RYN icon
363
Rayonier
RYN
$6.61B
$252K 0.01%
7,716
VRTX icon
364
Vertex Pharmaceuticals
VRTX
$123B
$252K 0.01%
1,251
IWF icon
365
iShares Russell 1000 Growth ETF
IWF
$128B
$250K 0.01%
3,680
TRP icon
366
TC Energy
TRP
$66.9B
$248K 0.01%
5,000
ELV icon
367
Elevance Health
ELV
$84.8B
$247K 0.01%
646
CMI icon
368
Cummins
CMI
$90.1B
$245K 0.01%
+1,005
New +$257K
OKTA icon
369
Okta
OKTA
$25.8B
$245K 0.01%
1,000
PTR
370
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
$245K 0.01%
+5,000
New +$203K
BDX icon
371
Becton Dickinson
BDX
$46.6B
$244K 0.01%
+1,030
New +$247K
BIIB icon
372
Biogen
BIIB
$30.5B
$244K 0.01%
+705
New +$214K
EEM icon
373
iShares MSCI Emerging Markets ETF
EEM
$29.7B
$244K 0.01%
4,425
BWA icon
374
BorgWarner
BWA
$13.8B
$243K 0.01%
5,682
IQV icon
375
IQVIA
IQV
$38.9B
$242K 0.01%
1,000
-600
-38% -$139K

Similar funds

R.H. Bluestein & Co's Q2 2021 Portfolio in Review

As of Q2 2021, R.H. Bluestein & Co held 443 positions worth $2.58B, up 9.1% from $2.36B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

R.H. Bluestein & Co's Q2 2021 filing shows 37 new, 128 increased, 97 reduced and 16 closed positions. Its largest new stake was Estee Lauder: 103,700 shares worth $33M. The largest sale was Freeport-McMoran, an estimated $50.2M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Industrials and Communication Services.

  • R.H. Bluestein & Co's largest Q2 2021 buy was Estee Lauder: 103,700 shares worth $33M.
  • R.H. Bluestein & Co added most to Netflix in Q2 2021, an estimated $23.5M increase.
  • R.H. Bluestein & Co's biggest Q2 2021 reduction was Freeport-McMoran, cutting an estimated $50.2M.
  • R.H. Bluestein & Co fully exited Warner Music in Q2 2021, selling an estimated $506K.
  • R.H. Bluestein & Co's ten largest holdings make up 40% of its $2.58B portfolio in Q2 2021.
  • R.H. Bluestein & Co opened 37 new positions and closed 16 in Q2 2021.
  • R.H. Bluestein & Co's portfolio value rose 9.1% quarter-over-quarter to $2.58B.

Based on R.H. Bluestein & Co's 13F filing for Q2 2021, filed 13 Aug 2021.